| Identifier |
19980323_nanos_posters_24 |
| Title |
Use of Cabergoline in Prolactinomas |
| Creator |
Fierz, Anna B; Kaufman, David I; Lee, Andrew G; Eggenberger, Eric R; Friend, Keith E |
| Subject |
Cabergoline; Prolactinomas; Bromocriptine |
| Description |
Bromocriptine (BRC), the standard medication for prolactinomas, is effective in most cases but has a short half-life and occasional side effects. Cabergoline (CAB, Dostinex) is a potent D2-selective dopamine agonist, FDA-approved since12/1996 for hyperprolactinemia. |
| Date |
1998-03-23 |
| Language |
eng |
| Format |
application/pdf |
| Format Creation |
application/pdf |
| Type |
Text |
| Source |
1998 North American Neuro-Ophthalmology Society Annual Meeting |
| Relation is Part of |
NANOS 1998: Poster Presentations (Session I) |
| Collection |
Neuro-ophthalmology Virtual Education Library: NOVEL http://NOVEL.utah.edu |
| Publisher |
Spencer S. Eccles Health Sciences Library, University of Utah |
| Holding Institution |
North American Neuro-Ophthalmology Association. NANOS Executive Office 5841 Cedar Lake Road, Suite 204, Minneapolis, MN 55416 |
| Rights Management |
Copyright 1998. For further information regarding the rights to this collection, please visit: https://NOVEL.utah.edu/about/copyright |
| ARK |
ark:/87278/s68088f5 |
| Context URL |
The NANOS Annual Meeting Neuro-Ophthalmology Collection: https://novel.utah.edu/collection/NAM/toc/ |
| Contributor Primary |
Fierz, Anna B |
| Setname |
ehsl_novel_nam |
| ID |
184315 |
| Reference URL |
https://collections.lib.utah.edu/ark:/87278/s68088f5 |
